Crowdonomics
WatchlistPortfolio
All companies
CADENCE OTC logo

CADENCE OTC

Operating

Cadence Healh, Inc.

Healthcare · Founded 2014

Visit website

Birth control without barriers

Valuation cap ⓘ
$73.0M
As of Apr 2024 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$14,594,994
Crowd $750K · Private $13.8M · 4 rounds since 2018

Financials

FY2021–FY2024 · from SEC filings · hover any figure for its source
$0
−$3.6M
2021
$0
−$9.9M
2022
$28K
−$4.9M
2023
$1.3M
−$5.2M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021 audited
FY2022 audited
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$0
$27,737
$1,317,041
Cost of goods sold
$0
$0
$17,498
$574,198
Gross margin
—
—
37%
56%
Net income
-$3,634,345
-$9,919,466
-$4,860,280
-$5,201,501
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$9,781,082
$6,676,902
$4,119,343
$5,861,884
Accounts receivable
$0
$0
$27,648
$428,908
Total assets
$18,392,477
$8,959,353
$6,639,883
$8,846,562
Short-term debt
$142,391
$388,308
$568,051
$1,619,632
Long-term debt
$708,532
$708,532
$708,532
$6,846,619
Total liabilities
$850,923
$1,096,840
$1,276,583
$8,466,251
Other
Headcount
—
6
—
6

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$73.0M
Valuation cap
Reg CF · Note · Mar 2024

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · Convertible Note · Mar 2024Closedvia WeFunder
Raised $750.2K / $3MInvestors 366Valuation cap $73M
Rule 506(b) · Equity · Jun 2020Closed
Raised $3.1MInvestors 3
Rule 506(b) · Equity · Jul 2019Closed
Raised $6.3MInvestors 16
Rule 506(b) · Equity · Feb 2018Closed
Raised $4.5MInvestors 11

Team

4 people
Robert HosangFounder
Chief Medical Officer, Co-Founder
Samantha MillerFounder
Co-Founder & CEO
Constance E. Evans
Board Director
Timothy Koogle
Board Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 1 of 3 annual reports (FY2023–FY2025)

Missing: 2023, 2025

366 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 17, 20250001670254-25-000374
    EDGAR
  • Form C/AApr 26, 20240001670254-24-000448
    EDGAR
  • Form C/AMar 15, 20240001670254-24-000227
    EDGAR
  • Form CMar 8, 20240001670254-24-000196
    EDGAR
  • Form DJun 16, 20200001732157-20-000001
    EDGAR
  • Form DAug 27, 20190001732157-19-000002
    EDGAR
  • Form DFeb 22, 20180001732157-18-000001
    EDGAR
Source: ManualCIK 0001732157

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.